Third-Party TestedPX13-R

Made in the USA

Peptides

142 in stock (cold storage)

PX13-R Triple Agonist

$124.99

PX13-R is a research peptide reference for combined GLP-1, GIP and glucagon receptor agonism.

142 in stock (cold storage)

Strength

Pack size

10-vial kits: 3 kit minimum.Kits (10 vials) are sold on the Buy Kits page, 3 kit minimum. Shop Buy Kits

1
Download COA

Earn up to 312 points · $3.12 back in Research Credit

Earn 2.5 pts / $1 · Redeem 100 pts = $1 · Covers up to 50% of an order · How points work

Same-day dispatch before 2:00 PM PacificFree UPS 2-Day over $250
142 in stock in cold storage
HPLC & LC-MS verified purity 99%+Lot-linked COA
  • Same-day dispatch before 2:00 PM Pacific · Free UPS 2-Day over $250
  • 142 in stock in cold storage
  • HPLC & LC-MS verified purity 99%+ · Lot-linked COA
We accept:AMEXDISC●VERACH$ZV

For research use only. Not for human or animal consumption.

Checking today's dispatch cutoff…

Cutoff is 2:00 PM Pacific on weekdays, 12:00 PM Pacific on Saturday.

Referral program · researchers save 15%, you earn 18% back

ILS Laboratories logo

Lot shipping PX1R10-0021 · 10mg

Certificate of Analysis

ILS Laboratories · Tested Jul 31, 2026

PX13-R 10mg

Lot PX1R10-0021 · Verified

99%+

Purity

HPLC

10.6mg

Net content

label 10mg · +6.0%

Confirmed

Identity

PX13-R · MS

  • HPLC purity
  • Mass spec
  • Net content
  • Lot matched
HPLC chromatogram for lot PX1R10-0021
Actual peak graph from signed COA
Meet the lab

About PX13-R

PX13-R • Research peptide • 10mg • 15mg • 20mg • 30mg • 40mg • 60mg • Third party tested • Research use only

Research peptide

PX13-R

PX13-R is a research peptide reference for combined GLP-1, GIP and glucagon receptor agonism.

Supplied as a research-grade compound for in-vitro and laboratory investigation.

10mg · 15mg · 20mg · 30mg · 40mg · 60mg

Strengths

99%+

HPLC purity

Lyophilized

Form

-20°C

Long-term storage

99%+ HPLC Purity

Independently verified by accredited US laboratory

Endotoxin-Screened

LAL tested, LPS-free, endotoxin report available

GMP-Certified Manufacturing

USA facility, ISO 9001:2015

Lyophilized for Stability

Shipped cold-packed and sealed for stability

What's in the vial

Identity. Weight. Sequence.

Molecular weight

4731.2 g/mol

Molecular formula

C₂₂₁H₃₄₂N₄₆O₆₈

CAS number

2381089-83-2

Chain length

39 amino acids

Classification: Research peptide

The complete primary structure is reported only when it can be verified for the exact compound and modification supplied.

Specifications & quality

Purity (HPLC)

99%+

Application

For Research Use only

Form

Lyophilized Powder

Storage

-20°C Long Term

Testing

Third Party Tested

Manufacture

USA

About this compound

PX13-R (LY3437943) — Triple-Agonist Research Peptide

PX13-R is PX1 Research's catalog name for LY3437943, a synthetic 39-residue peptide engineered to act at three receptors at once: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon receptor (GCGR). Because one molecule engages all three incretin and glucagon pathways, it is described in the literature as a triple agonist, the step beyond single GLP-1 analogs (PX1-S) and dual GIP/GLP-1 agonists (PX12-T).

Research context

The discovery and preclinical pharmacology of LY3437943 were reported by Coskun and colleagues in Cell Metabolism (2022), including receptor-binding and signaling data across the three targets and studies in rodent metabolic models. The compound was later evaluated in phase 2 clinical studies reported in The New England Journal of Medicine (Jastreboff et al., 2023) and The Lancet (Rosenstock et al., 2023). In laboratory work it is used to study:

  • Receptor selectivity and potency across GLP-1R, GIPR and GCGR in cell-based assays
  • Incretin and glucagon signaling cross-talk, cAMP response and receptor desensitization
  • Comparative pharmacology against single and dual agonists in metabolic research models
  • Fatty-acid acylation and albumin binding as drivers of extended half-life

Published findings describe the compound's behavior in those study systems only. They do not establish any outcome for the material supplied here.

Analytical considerations

LY3437943 contains non-coded amino acids and a C20 fatty-diacid side chain, so identity is confirmed by LC-MS against the theoretical mass and purity is assessed by reversed-phase HPLC. The lot-linked Certificate of Analysis on this page reports the results for the material you receive.

PX13-R specifications

  • Research code: LY3437943
  • CAS Number: 2381089-83-2
  • Molecular Formula: C221H342N46O68
  • Molecular Weight: ≈4731.2 g/mol
  • Length: 39 amino acids, acylated
  • Form: Lyophilized white to off-white powder in a sealed glass vial
  • Strengths: shown in the strength options on this page
  • Storage: Sealed at −20 °C, dry and protected from light

Laboratory handling

Bring the closed vial to room temperature before opening, prepare solutions according to your laboratory's validated protocol, and record the lot number, concentration and storage conditions. Avoid repeated freeze–thaw cycles once the material is in solution.

Common research questions

What does "triple agonist" mean? The peptide activates GLP-1, GIP and glucagon receptors from a single molecule, rather than one (PX1-S) or two (PX12-T) of them.

How is PX13-R different from PX12-T? PX12-T acts at GIP and GLP-1 receptors. PX13-R adds glucagon-receptor activity, which is why the two are often compared side by side in receptor-pharmacology studies.

How do I check the lot I received? Match the lot number on your vial to the Certificate of Analysis shown on this page.

References

  1. Coskun T, et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept. Cell Metabolism. 2022.
  2. Jastreboff AM, et al. Phase 2 trial of LY3437943 in obesity. N Engl J Med. 2023.
  3. Rosenstock J, et al. Phase 2 trial of LY3437943 in type 2 diabetes. The Lancet. 2023.

Intended use

For research use only. Not for human or veterinary use, consumption, diagnosis, treatment or medical application. This material should be handled only by qualified professionals in an appropriate laboratory setting.

Safety Data Sheet

Full GHS 16-section Safety Data Sheet for PX13-R, prepared per OSHA HazCom 2012 (29 CFR 1910.1200). Includes substance identity, handling & storage, PPE, stability, transport and regulatory information.

CAS No.

2381089-83-2

Formula

C₂₂₁H₃₄₂N₄₆O₆₈

Mol. Weight

4731.2 g/mol

Classification

Not hazardous (GHS)

Compound data · Chemical identity

What is PX13-R (LY-3437943)?

PX13-R (LY-3437943) is an investigational triple-hormone-receptor agonist that binds the GLP-1, GIP and glucagon receptors in a single 39-amino-acid peptide. In metabolic research models it influences glucose homeostasis, appetite signaling and energy expenditure with greater potency than dual or single incretin analogs.

PX13-R chemical & technical data

Compound namePX13-R
Research codeLY-3437943
CAS registry number2381089-83-2
Molecular formulaC221H342N46O68
Molar mass≈4730.4 g/mol
Chain length39 amino acids
Reported half-life≈6 days (reported in published pharmacokinetic literature)
Physical formLyophilized white powder, acetate salt
Purity specification≥99% by reversed-phase HPLC; identity confirmed by LC-MS
Intended useResearch use only — not for human or veterinary use

PX13-R vs PX12-T vs PX1-S (research reference)

PropertyPX13-RPX12-TPX1-S
Receptor targetsGLP-1 / GIP / glucagon (triple)GLP-1 / GIP (dual)GLP-1 (single)
Development codeLY-3437943LY-3298176NN9535
Chain length39 amino acids39 amino acids31 amino acids
Molar mass≈4730 g/mol≈4813 g/mol≈4114 g/mol
Reported plasma half-life≈6 days≈5 days≈7 days
Lyophilized presentationVial, acetate saltVial, acetate saltVial, acetate salt

Questions & answers

PX13-R frequently asked questions

High Quality · 99% Purity Guaranteed

Product Quality Guarantee

We are continuously conducting HPLC testing on all of our raw powders as well as our finished products to ensure the quality of what we ship. You can have the product you bought from us independently tested at any HPLC-licensed testing facility, and if the results come back negative, we will refund the following:

HPLC Test Fee

$100

Plus a full refund

Total order amount + shipping

For laboratory research use only. Not for human or animal consumption.

PX13-R10mg / 1 Vial

$124.99

1